Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time-Reference-Cited by-同舟云学术

Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time

Published:2008-06-01 Issue:6 Volume:93 Page:925-929
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Balduzzi A.,De Lorenzo P.,Schrauder A.,Conter V.,Uderzo C.,Peters C.,Klingebiel T.,Stary J.,Felice M. S.,Magyarosy E.,Schrappe M.,Dini G.,Gadner H.,Valsecchi M. G.

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM study;Blood Advances;2024-01-12

2. Clinical experience of CAR T cells for B cell acute lymphoblastic leukemia;Best Practice & Research Clinical Haematology;2021-09

3. Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?;Biomarker Research;2020-11-25

4. Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant;Bone Marrow Transplantation;2020-05-10

5. Superior survival of unmanipulated haploidentical haematopoietic stem cell transplantation compared with intensive chemotherapy as post‐remission treatment for children with very high‐risk philadelphia chromosome negative B‐cell acute lymphoblastic leukaemia in first complete remission;British Journal of Haematology;2019-11-14